iSpecimen Inc. (ISPC) vs Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
A side-by-side comparison of iSpecimen Inc. and Shuttle Pharmaceuticals Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ISPC
iSpecimen Inc.
$1.06HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$4.06HealthcareDelayed quote: Oct 6, 2026, 12:53 PM EDT
Total return — ISPC vs SHPH
growth of $100 · dividends reinvested · last 4yISPC -99.9% (-84.4%/yr)SHPH -100.0% (-91.5%/yr)ISPC compounded faster over this window
Log scale — wide-divergence pair
ISPC SHPH
ISPC vs SHPH: by the numbers
- •ISPC is the larger company ($3M vs $2M market cap).
- •Both run net losses; SHPH's is the smaller (0.00% vs -2449.04% net margin).
Metrics side by side
Valuation
| Metric | ISPC | SHPH |
|---|---|---|
| P/S ratio | 5.73 | N/A |
| P/B ratio | 1.54 | 0.12 |
Profitability
| Metric | ISPC | SHPH |
|---|---|---|
| Gross margin | 1.25% | 0.00% |
| Operating margin | -465.42% | 0.00% |
| Net margin | -2449.04% | 0.00% |
| ROE | -657.69% | -53.49% |
| ROIC | -476.39% | -58.05% |
Growth (annualized)
| Metric | ISPC | SHPH |
|---|---|---|
| Revenue CAGR (5Y) | -46.70% | N/A |
| Total return CAGR (5Y) | -81.14% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.